ScreenerHero

VISTN Vistin Pharma ASA

OSL · NO · Healthcare · Drug Manufacturers - Specialty & Generic · vistin.com
18.10NOK-0.82%Mkt Cap: 75.65M $P/E: 11.55

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; m…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap75.65M USD
Enterprise Value76.44M USD
Revenue (TTM)40.38M USD
Gross Profit21.68M USD
Net Income (TTM)6.99M USD
Revenue/Share9.74 NOK
Last Price18.10 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees74
CountryNO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)11.55
P/E (Forward)—
PEG—
EV/EBITDA7.95
EV/Revenue1.89
P/S1.87
P/B2.53
EPS (TTM)1.58
EPS (Forward)—
52W Range
17.707% of range23.70
52W High23.70 NOK
52W Low17.70 NOK
Profitability
Gross Margin51.28%
Oper. Margin16.02%
EBITDA Margin23.81%
Profit Margin16.53%
ROE22.73%
ROA17.01%
Growth
Revenue Growth-14.80%
Earnings Growth-23.50%
Cash Flow & Leverage
Operating CF7.29M USD
CapEx (TTM)1.56M USD
FCF Margin10.01%
FCF Yield5.34%
Net Debt787.93K USD
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity0.00
Current Ratio2.49
Quick Ratio1.52
Book Value/Sh7.22 NOK
Cash/Share0.18 NOK
Dividends
Fwd Div Rate1.00 NOK
Trail. Div Rate1.50 NOK
Div. Yield5.48%
5Y Avg Yield—
Payout Ratio62.98%
Ex-Div DateMay 22, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.44.34M
Float20.69M
Insiders61.16%
Institutions13.74%
Technical
SMA 5019.25 (-6.0%)
SMA 20020.74 (-12.7%)
Beta0.58
S&P 52W Chg16.45%
Avg Vol (30d)10.36K
Avg Vol (10d)6.48K
Technical Indicators
RSI (14)39.0
MACD-0.2774
MACD Signal-0.3047
MACD Hist.+0.0273
BB Upper19.09 NOK
BB Middle18.48 NOK
BB Lower17.88 NOK
BB Width6.60%
ATR (14)0.3965 NOK
Vol Ratio (20d)0.09x